Subscribe
|
Contact Us
|
AltheaDx Raises $6 Million Series A Venture Capital
Thursday, April 15, 2010
5:56:00 AM PDT | VentureDeal Staff
San Diego, California -- biotechnology development company
AltheaDx
has secured $6 million in its first round of institutional venture capital investment.
AltheaDx has developed a proprietary gene expression profiling technology for differential diagnosis of pediatric cancers and improve diagnosis of prostate cancer.
Telegraph Hill Partners led the round, which included other undisclosed investors. The companies said it would use the funding proceeds to support its existing partnerships.
Email Page
|
Print Page
Loading
Want unlimited access to the
complete database
with thousands of technology companies, VCs and transactions for only $25 per month?
Start your
Free 14 Day Trial
now – no obligation or credit card required.
